LEXARIA BIOSCIENCE CORP. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price
LEXARIA BIOSCIENCE CORP. (LEXX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price of $1.41 per share for the 12-month period ending 2025-08-31, per its 10-K filed 2025-11-28.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice · last filed 2025-11-28
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, outstanding, period increase (decrease), weighted average exercise price for fiscal 2025 was $1.41, a 51.55% decline from fiscal 2024.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, outstanding, period increase (decrease), weighted average exercise price for fiscal 2024 was $2.91, a 66.29% increase from fiscal 2023.
- LEXARIA BIOSCIENCE CORP. share-based compensation arrangement by share-based payment award, options, outstanding, period increase (decrease), weighted average exercise price for fiscal 2023 was $1.75.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price 12 month |
|---|---|
| 2025-08-31 | $1.41 10-K · filed 2025-11-28 |
| 2024-08-31 | $2.91 10-K · filed 2025-11-28 |
| 2023-08-31 | $1.75 10-K · filed 2024-11-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |